Phreesia (PHR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for June 25, 2025, to be held virtually, with voting on director elections, auditor ratification, and executive compensation approval.
Shareholders of record as of May 1, 2025, are eligible to vote; 59,459,706 shares outstanding.
Board recommends voting FOR all proposals, including director nominees, auditor ratification, and executive compensation.
Proxy materials are primarily distributed electronically to reduce environmental impact and costs.
Voting matters and shareholder proposals
Election of two Class III directors (Gillian Munson and Mark Smith, M.D.) to serve until 2028.
Ratification of KPMG LLP as independent registered public accounting firm for fiscal year ending January 31, 2026.
Non-binding, advisory vote on executive compensation (say-on-pay).
Shareholders may submit proposals for the 2026 meeting by January 14, 2026, and nominations between February 25 and March 27, 2026.
Board of directors and corporate governance
Board consists of eight members, with seven independent directors.
Board is divided into three staggered classes; annual elections for one class.
Separate Chair and CEO roles; strong focus on independence and diversity (62.5% diverse in gender or race/ethnicity).
Board committees (audit, compensation, nominating/governance) are fully independent.
Annual board and committee evaluations; stock ownership guidelines for directors and executives.
Latest events from Phreesia
- 19% revenue growth, positive free cash flow, and improved EBITDA mark a strong Q2 FY25.PHR
Q2 202522 Jan 2026 - Revenue up 17%, net loss narrowed, and Adjusted EBITDA positive with strong outlooks ahead.PHR
Q3 202511 Jan 2026 - Double-digit revenue growth, positive cash flow, and strong 2026 outlook maintained.PHR
Q4 202526 Dec 2025 - Q3 FY2026 saw 13% revenue growth, profitability, and a major acquisition completed.PHR
Q3 20269 Dec 2025 - Key votes include director elections, auditor ratification, and executive pay approval.PHR
Proxy Filing1 Dec 2025 - Q1 FY2026 revenue up 15%, net loss narrows, EBITDA and free cash flow surge, guidance raised.PHR
Q1 202626 Nov 2025 - Achieved first positive net income, 15% revenue growth, and announced $160M AccessOne acquisition.PHR
Q2 202620 Oct 2025